Brief: Ying Luo Reports 8.54% Stake In Gyre Therapeutics As Of September 6- SEC Filing
06/09/2024 14:03
Gyre Therapeutics Inc GYRE.O :
* YING LUO REPORTS 8.54% STAKE IN GYRE THERAPEUTICS AS OF
SEPTEMBER 6- SEC FILING
Source text for Eikon: ID:n0001140361-24-040313
Further company coverage: GYRE.O
Recent news on Gyre Therapeutics
See all newsBrief: Gyre Therapeutics - Enters Employment Agreement With Ying Luo As CEO - SEC Filing
Gyre Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Gyre Therapeutics, Inc. expected to post a loss of 13 cents a share - Earnings Preview
Brief: Gyre Therapeutics Reports Second Quarter 2026
Gyre Therapeutics Q2 revenue beats estimates on higher ETUARY sales volumes